Diabetes Care, Vol 21, Issue 5 682-686, Copyright © 1998 by American Diabetes Association

ARTICLES

The effect of magnesium supplementation in increasing doses on the control of type 2 diabetes

Md Lima, T Cruz, JC Pousada, LE Rodrigues, K Barbosa and V Cangucu
Department of Medicine, Bahia Federal University Medical School, Brazil.

OBJECTIVE: Hypomagnesemia occurs in 25-38% of patients with type 2 diabetes. Several studies have suggested an association between magnesium (Mg) depletion and insulin resistance and/or reduction of insulin secretion in these cases. Our purpose was to evaluate if Mg supplementation (as magnesium oxide [MgO]) would improve metabolic control in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: We studied 128 patients with type 2 diabetes (32 men, 96 women, aged 30-69 years), treated by diet or diet plus oral antidiabetic drugs, in the Bahia Federal University Hospital, Brazil. Patients at risk for hypomagnesemia or with reduced renal function were excluded. This study was a clinical randomized double-blind placebo-controlled trial. Patients received either placebo, 20.7 mmol MgO, or 41.4 mmol MgO daily (elementary Mg) for 30 days. Mg concentrations were measured in plasma, in mononuclear cells, and in 24-h urine samples. Fasting blood glucose, HbA1, and fructosamine were used as parameters of metabolic control. RESULTS: Of the patients, 47.7% had low plasma Mg, and 31.1% had low intramononuclear Mg levels. Intracellular Mg in patients with diabetes was significantly lower than in the normal population (62 blood donors; 1.4 +/- 0.6 vs. 1.7 +/- 0.6 micrograms/mg of total proteins). No correlation was found between plasma and intracellular Mg concentrations (r = -0.179; P = 0.15) or between Mg concentrations and glycemic control (r = -0.165; P = 0.12). Intracellular Mg levels were lower in patients with peripheral neuropathy than in those without (1.2 +/- 0.5 vs. 1.5 +/- 0.6 micrograms/mg). Similar findings were observed in patients with coronary disease (1.0 +/- 0.5 vs. 1.5 +/- 0.6 micrograms/mg). In the placebo and in the 20.7 mmol Mg groups, neither a change in plasma and intracellular levels nor an improvement in glycemic control were observed. Replacement with 41.4 mmol Mg tended to increase plasma, cellular, and urine Mg and caused a significant fall (4.1 +/- 0.8 to 3.8 +/- 0.7 mmol/l) in fructosamine (normal, 1.87-2.87 mmol/l). CONCLUSIONS: Mg depletion is common in poorly controlled patients with type 2 diabetes, especially in those with neuropathy or coronary disease. More prolonged use of Mg in doses that are higher than usual is needed to establish its routine or selective administration in patients with type 2 diabetes to improve control or prevent chronic complications.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				P.-C. T. Pham, P.-M. T. Pham, S. V. Pham, J. M. Miller, and P.-T. T. Pham Hypomagnesemia in Patients with Type 2 Diabetes Clin. J. Am. Soc. Nephrol., March 1, 2007; 2(2): 366 - 373. [Abstract] [Full Text] [PDF]

				M. E. Rumawas, N. M. McKeown, G. Rogers, J. B. Meigs, P. W.F. Wilson, and P. F. Jacques Magnesium Intake Is Related to Improved Insulin Homeostasis in the Framingham Offspring Cohort J. Am. Coll. Nutr., December 1, 2006; 25(6): 486 - 492. [Abstract] [Full Text] [PDF]

				E. C. Chambers, S. Heshka, D. Gallagher, J. Wang, F. X. Pi-Sunyer, and R. N. Pierson Jr Serum Magnesium and Type-2 Diabetes in African Americans and Hispanics: A New York Cohort J. Am. Coll. Nutr., December 1, 2006; 25(6): 509 - 513. [Abstract] [Full Text] [PDF]

				S. Bo, M. Durazzo, S. Guidi, M. Carello, C. Sacerdote, B. Silli, R. Rosato, M. Cassader, L. Gentile, and G. Pagano Dietary magnesium and fiber intakes and inflammatory and metabolic indicators in middle-aged subjects from a population-based cohort. Am. J. Clinical Nutrition, November 1, 2006; 84(5): 1062 - 1069. [Abstract] [Full Text] [PDF]

				Y. Song, J. E. Manson, J. E. Buring, and S. Liu Dietary Magnesium Intake in Relation to Plasma Insulin Levels and Risk of Type 2 Diabetes in Women Diabetes Care, January 1, 2004; 27(1): 59 - 65. [Abstract] [Full Text] [PDF]

				R. Lopez-Ridaura, W. C. Willett, E. B. Rimm, S. Liu, M. J. Stampfer, J. E. Manson, and F. B. Hu Magnesium Intake and Risk of Type 2 Diabetes in Men and Women Diabetes Care, January 1, 2004; 27(1): 134 - 140. [Abstract] [Full Text] [PDF]

				J. L. Nadler A New Dietary Approach to Reduce the Risk of Type 2 Diabetes? Diabetes Care, January 1, 2004; 27(1): 270 - 271. [Full Text] [PDF]

				M. Rodriguez-Moran and F. Guerrero-Romero Oral Magnesium Supplementation Improves Insulin Sensitivity and Metabolic Control in Type 2 Diabetic Subjects: A randomized double-blind controlled trial Diabetes Care, April 1, 2003; 26(4): 1147 - 1152. [Abstract] [Full Text] [PDF]

				G. Y. Yeh, D. M. Eisenberg, T. J. Kaptchuk, and R. S. Phillips Systematic Review of Herbs and Dietary Supplements for Glycemic Control in Diabetes Diabetes Care, April 1, 2003; 26(4): 1277 - 1294. [Abstract] [Full Text] [PDF]

				J. Davies and A. Struthers Review: The potential benefits of aldosterone antagonism in Type 2 diabetes mellitus Journal of Renin-Angiotensin-Aldosterone System, September 1, 2002; 3(3): 150 - 155. [Abstract] [PDF]

				B. S. O'Connell Select Vitamins and Minerals in the Management of Diabetes Diabetes Spectr, August 1, 2001; 14(3): 133 - 148. [Abstract] [Full Text] [PDF]

				A. V. Möllsten, G. G. Dahlquist, E.-L. Stattin, and S. Rudberg Higher Intakes of Fish Protein Are Related to a Lower Risk of Microalbuminuria in Young Swedish Type 1 Diabetic Patients Diabetes Care, May 1, 2001; 24(5): 805 - 810. [Abstract] [Full Text]

				E. S. Ford Vitamin Supplement Use and Diabetes Mellitus Incidence among Adults in the United States Am. J. Epidemiol., May 1, 2001; 153(9): 892 - 897. [Abstract] [Full Text] [PDF]